FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns drugs and covers a combination applicable for treating a respiratory disease representing asthma, acute or chronic bronchitis, emphysema, chronic obstructive pulmonary disease, bronchial hyperactivity or rhinitis, containing effective amount of (a) corticosteroid and effective amount of (b) M3 muscarine receptors antagonist which represents 3(R)-(2-hydroxy-2,2-dithiene-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane in the form of salt containing anion X which is pharmaceutically acceptable anion of mono-or polyvalent acid. There is also disclosed application of 3(R)-(2-hydroxy-2,2-dithiene-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane and corticosteroid for preparing a drug for treating a respiratory disease and the method of treating said respiratory disease.
EFFECT: combinations under the invention provide improved therapeutic effect in treating the respiratory diseases.
21 cl, 1 dwg, 1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINATIONS, CONNECTING ANTI-MUSCARINIC PREPARATIONS AND BETA-ADRENERTIC AGONISTS | 2010 |
|
RU2465902C2 |
COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2404771C2 |
COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS | 2005 |
|
RU2373935C2 |
COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385156C2 |
COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND INHIBITORS PDE4 | 2005 |
|
RU2404772C2 |
5-(2-{[6-(2,2-DIFLURO-2-PHENYLETHOXY)HEXYL]AMINO}-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE HEMINAPADISYLATE AS β2 ADRENERGIC RECEPTOR AGONIST | 2008 |
|
RU2495029C2 |
NEW DOSE AND FORMULATION | 2009 |
|
RU2608713C2 |
COMBINATIONS CONTAINING ANTI-MUSCARINE PREPARATIONS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2379033C2 |
QUINUCLIDINE ANALOGS, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF RESPIRATORY DISEASES | 2000 |
|
RU2306312C2 |
QUINUCLIDINE DERIVATIVES, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT AND INTERMEDIATE SUBSTANCES | 2000 |
|
RU2264401C2 |
Authors
Dates
2010-04-10—Published
2005-05-31—Filed